Total submissions: 6
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Women's Health and Genetics/Laboratory Corporation of America, |
RCV000589533 | SCV000694268 | uncertain significance | not provided | 2016-05-27 | criteria provided, single submitter | clinical testing | Variant summary: c.3994-9C>T in ATM gene is an intronic change that involves a non-conserved nucleotide. 5/5 programs in Alamut predict that this variant enhance the acceptor cite, however no functional studies supporting this notion were published at the time of evaluation. The variant is present in the control population dataset of ExAC at frequency of 0.000009 (1/112916 chrs tested). The observed frequency does not exceed the maximum expected allele frequency for a pathogenic variant of 0.0005, suggesting that it is not a common polymorphism. The variant of interest has not, to our knowledge, been reported in affected individuals in published reports or cited by reputable databases/clinical laboratory. Taking together the variant was classified as VUS until additional information becomes available. |
Labcorp Genetics |
RCV001078690 | SCV000749156 | likely benign | Ataxia-telangiectasia syndrome | 2023-07-19 | criteria provided, single submitter | clinical testing | |
Color Diagnostics, |
RCV001191541 | SCV001359400 | likely benign | Hereditary cancer-predisposing syndrome | 2019-06-26 | criteria provided, single submitter | clinical testing | |
Gene |
RCV000589533 | SCV001780467 | likely benign | not provided | 2020-10-21 | criteria provided, single submitter | clinical testing | |
Myriad Genetics, |
RCV004592900 | SCV005082306 | likely benign | Familial cancer of breast | 2024-05-16 | criteria provided, single submitter | clinical testing | This variant is considered likely benign. This variant is intronic and is not expected to impact mRNA splicing. |
Prevention |
RCV004553304 | SCV004776677 | likely benign | ATM-related disorder | 2019-09-03 | no assertion criteria provided | clinical testing | This variant is classified as likely benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). |